Chile’s National Economic Prosecutor (FNE) has said it received a new complaint regarding possible instances of collusion between major drug-store chains, this time affecting the Valdivia region. The complaint, presented by the Movimiento Autónomo Regional de Los Rios (Los Rios Autonomous Regional Movement), has sought to bring attention to this problem, which they claim affects several communal areas.
Miguel Ángel Carrasco, a physician and member of the Los Ríos movement, explained that their suspicions were raised due to the minimal difference in prices found among the most common medications used by Chilean consumers. The group has gathered and presented the FNE with data collected from communal villages in the Valdivia and Union regions, with price comparisons for various brands of medication, including anti-inflammatory and anti-anxiety medication.
Full Content: Bio Bio Chile
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC Pushes Review of CoStar’s Commercial Real Estate Antitrust Case
Jan 31, 2024 by
CPI
UK’s CMA Investigates Ardonagh’s Atlanta Group and Markerstudy Merger
Jan 31, 2024 by
CPI
Greenberg Traurig Grow Financial Regulatory and Compliance Practice
Jan 31, 2024 by
CPI
Dutch Regulator Fines Uber €10 Million for Privacy Violations
Jan 31, 2024 by
CPI
DOJ Investigates AI Competition, Eyes Microsoft’s OpenAI Deal: Bloomberg
Jan 31, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Rule(s) of Reason
Jan 29, 2024 by
CPI
Evolving the Rule of Reason for Legacy Business Conduct
Jan 29, 2024 by
CPI
The Object Identity
Jan 29, 2024 by
CPI
In Praise of Rules-Based Antitrust
Jan 29, 2024 by
CPI
The Future of State AG Antitrust Enforcement and Federal-State Cooperation
Jan 29, 2024 by
CPI